REQUEST A DEMO
Total
USD $0.00
Search more companies

Astrazeneca Pharma Poland Sp. z o.o. (Poland)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Astrazeneca Pharma Poland Sp. z o.o. Profile Updated: November 22, 2021
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English & Polish Download a sample report

Astrazeneca Pharma Poland Sp. z o.o. is an enterprise based in Poland. Its main office is in Warsaw. The company operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) industry. The company was established on June 13, 2002. It currently has a total number of 1,200 (2021) employees. The latest financial highlights indicate a net sales revenue increase of 30.78% in 2021. Its’ total assets recorded a growth of 46.88%. The net profit margin of Astrazeneca Pharma Poland Sp. z o.o. increased by 0.24% in 2021.

Headquarters
Ul. Postepu 14
Warsaw; Mazowieckie; Postal Code: 02-676

Contact Details: Purchase the Astrazeneca Pharma Poland Sp. z o.o. report to view the information.

Website: http://www.astrazeneca.com

Basic Information
Total Employees:
Purchase the Astrazeneca Pharma Poland Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Astrazeneca Pharma Poland Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Astrazeneca Pharma Poland Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Astrazeneca Pharma Poland Sp. z o.o. report to view the information.
Incorporation Date:
June 13, 2002
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Vice President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Astrazeneca Pharma Poland Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
30.78%
Total operating revenue
30.75%
Operating profit (EBIT)
32.83%
EBITDA
29.28%
Net Profit (Loss) for the Period
34.62%
Total assets
46.88%
Total equity
34.12%
Operating Profit Margin (ROS)
0.12%
Net Profit Margin
0.24%
Return on Equity (ROE)
0.09%
Quick Ratio
-0.34%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?